188 related articles for article (PubMed ID: 37554517)
1. Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex.
Tollenaere MAX; Mølck C; Henderson I; Pollack S; Addis P; Petersen HH; Norsgaard H
JID Innov; 2023 Sep; 3(5):100214. PubMed ID: 37554517
[TBL] [Abstract][Full Text] [Related]
2. Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2.
Popovic B; Breed J; Rees DG; Gardener MJ; Vinall LM; Kemp B; Spooner J; Keen J; Minter R; Uddin F; Colice G; Wilkinson T; Vaughan T; May RD
J Mol Biol; 2017 Jan; 429(2):208-219. PubMed ID: 27956146
[TBL] [Abstract][Full Text] [Related]
3. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro.
Zheng T; Zhu Z; Liu W; Lee CG; Chen Q; Homer RJ; Elias JA
J Allergy Clin Immunol; 2003 Apr; 111(4):720-8. PubMed ID: 12704349
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of the interleukin-13 receptor complex.
Andrews AL; Holloway JW; Puddicombe SM; Holgate ST; Davies DE
J Biol Chem; 2002 Nov; 277(48):46073-8. PubMed ID: 12354755
[TBL] [Abstract][Full Text] [Related]
5. The association of the cytoplasmic domains of interleukin 4 receptor alpha and interleukin 13 receptor alpha 2 regulates interleukin 4 signaling.
Andrews AL; Nordgren IK; Campbell-Harding G; Holloway JW; Holgate ST; Davies DE; Tavassoli A
Mol Biosyst; 2013 Dec; 9(12):3009-14. PubMed ID: 24056919
[TBL] [Abstract][Full Text] [Related]
6. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
[TBL] [Abstract][Full Text] [Related]
7. Endogenously expressed IL-13Rα2 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts.
Chandriani S; DePianto DJ; N'Diaye EN; Abbas AR; Jackman J; Bevers J; Ramirez-Carrozzi V; Pappu R; Kauder SE; Toy K; Ha C; Modrusan Z; Wu LC; Collard HR; Wolters PJ; Egen JG; Arron JR
J Immunol; 2014 Jul; 193(1):111-9. PubMed ID: 24879793
[TBL] [Abstract][Full Text] [Related]
8. Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab.
Okragly AJ; Ryuzoji A; Wulur I; Daniels M; Van Horn RD; Patel CN; Benschop RJ
Dermatol Ther (Heidelb); 2023 Jul; 13(7):1535-1547. PubMed ID: 37310643
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
Arima K; Sato K; Tanaka G; Kanaji S; Terada T; Honjo E; Kuroki R; Matsuo Y; Izuhara K
J Biol Chem; 2005 Jul; 280(26):24915-22. PubMed ID: 15870068
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
11. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.
Kawakami K; Taguchi J; Murata T; Puri RK
Blood; 2001 May; 97(9):2673-9. PubMed ID: 11313257
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic tail of IL-13Ralpha2 regulates IL-4 signal transduction.
Andrews AL; Nordgren IK; Kirby I; Holloway JW; Holgate ST; Davies DE; Tavassoli A
Biochem Soc Trans; 2009 Aug; 37(Pt 4):873-6. PubMed ID: 19614610
[TBL] [Abstract][Full Text] [Related]
13. Two copies of the genes encoding the subunits of putative interleukin (IL)-4/IL-13 receptors, IL-4Rα, IL-13Rα1 and IL-13Rα2, have been identified in rainbow trout (Oncorhynchus mykiss) and have complex patterns of expression and modulation.
Wang T; Huang W; Costa MM; Martin SA; Secombes CJ
Immunogenetics; 2011 Apr; 63(4):235-53. PubMed ID: 21210100
[TBL] [Abstract][Full Text] [Related]
14. IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts.
Andrews AL; Nasir T; Bucchieri F; Holloway JW; Holgate ST; Davies DE
J Allergy Clin Immunol; 2006 Oct; 118(4):858-65. PubMed ID: 17030238
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
16. IL-13 receptor isoforms: breaking through the complexity.
Tabata Y; Khurana Hershey GK
Curr Allergy Asthma Rep; 2007 Sep; 7(5):338-45. PubMed ID: 17697639
[TBL] [Abstract][Full Text] [Related]
17. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms.
Tabata Y; Chen W; Warrier MR; Gibson AM; Daines MO; Hershey GK
J Immunol; 2006 Dec; 177(11):7905-12. PubMed ID: 17114462
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.
Andrews R; Rosa L; Daines M; Khurana Hershey G
J Immunol; 2001 Feb; 166(3):1716-22. PubMed ID: 11160216
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
Zhao Y; He D; Zhao J; Wang L; Leff AR; Spannhake EW; Georas S; Natarajan V
J Biol Chem; 2007 Apr; 282(14):10172-9. PubMed ID: 17287216
[TBL] [Abstract][Full Text] [Related]
20. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
Daines MO; Tabata Y; Walker BA; Chen W; Warrier MR; Basu S; Hershey GK
J Immunol; 2006 Jun; 176(12):7495-501. PubMed ID: 16751396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
